T2 Bio & Health Tech
by main topic: 82
Issues 9
- IssueAquatic Breakthroughs1 trends · 0 signals
- IssueClothes that Care1 trends · 0 signals
- IssueContinuous behavioural sensing joined to genomics1 trends · 0 signals
- IssueDesigner Cells1 trends · 0 signals
- IssueFully autonomous laboratories draw capital but remain outside mainstream practice1 trends · 1 signals
- IssueLife sciences: from conglomerate to orchestrated Bioweave1 trends · 0 signals
- IssueOrgan Printing1 trends · 0 signals
- IssueTestosterone moves from medical treatment to lifestyle optimization without a boundary1 trends · 0 signals
- IssueViral Solution1 trends · 0 signals
Trends 12
- TrendA single treatment opens a wider pathway of behaviour, support, and spending2 signals
- TrendGenetic risk assessment is being paired with behavioral health coaching2 signals
- TrendMen's hormonal, metabolic and environmental health becomes a contested biological frontier2 signals
- TrendNeurotechnology and affect sensing move from clinic to consumer device7 signals
- TrendNon-hallucinogenic neuroplastogens shift the field from the trip to the underlying biology2 signals
- TrendPharma: payers demand real-world value while regulators tighten scrutiny of AI and data integrity2 signals
- TrendSleep diagnosis migrates from clinical labs to home testing and telemedicine3 signals
- TrendTechnology 6: the body's own vesicles are engineered as drug carriers3 signals
- TrendTechnology 7: a vaccine synthesized around one patient's tumour mutations4 signals
- TrendThe human-machine hybrid12 signals
- TrendTrend 6: healthcare becomes the proving ground for voice AI3 signals
- TrendTrend 7: pharmaceutical R&D shifts from manual experimentation to AI-guided discovery3 signals
Signals 61
- Signal'Almost Alive': Scientists built artificial cell-like blob 'SpudCell' that eats, grows, and divides
- Signal75% of Gen Z and 73% of millennials use health-tracking tools against 32% of boomers
- Signal80% use a health app or wearable, rising above 90% in the UAE and Saudi Arabia
- SignalA 50% probability of longevity escape velocity by the mid-to-late 2030s
- SignalA carmaker reports 83% fewer injuries from 75 exoskeleton units
- SignalA global pharma company simulates enrollment and diversity targets on a clinical-trial digital twin
- SignalA supplement that changed how subjects judged unfairness
- SignalA trillion-dollar drugmaker builds a discovery supercomputer with a chip vendor
- SignalAI agents in early drug discovery raised wet lab capacity 21 to 30 percent at one company
- SignalAI diagnostics lift sensitivity from 72% to 80%; drug discovery success from 10% to 70%
- SignalAbout nine in 10 clinical drug candidates fail, which the chapter partly attributes to computing error
- SignalAn autonomous surgical robot completes gallbladder surgery at reported 100% accuracy
- SignalAn estimated $79.4 billion of public investment built the mRNA infrastructure now reused
- SignalBROADMIND non-surgical brain-computer interface EEG kit (Kickstarter)
- SignalBlood biomarkers can forecast the onset of ALS symptoms
- SignalBrain-computer interface market projected to quadruple by 2034
- SignalBrainwave readings used to close a car sale
- SignalBrainwave-sensing headphones marketed for focus and burnout prevention
- SignalBrazil's GLP-1 patents expired in March 2026 and price is the stated barrier for 35% of interested consumers
- SignalCRISPR Boosts Potato Resistance to Late Blight Disease / Plant viruses open new routes for gene editing
- SignalCRISPR Clinical Trials 2026: In Vivo Delivery as the Single Most Important Transition
- SignalCRISPR moves from rare blood disorders towards common cardiovascular risk
- SignalCedars-Sinai Phase 3 trial shows deramiocel cell therapy preserves cardiac function in Duchenne muscular dystrophy
- SignalClearmind's MEAI candidate is named in US veterans legislation and enters Yale and Johns Hopkins trials
- SignalConsumer earbuds patented as biosignal sensors
- SignalCutlery that produces saltiness electrically
- SignalDietary advice from gut flora, blood work and glucose response
- SignalDiets derived from a customer's genetic profile
- SignalExoskeleton market projected to grow fourteenfold to 2035
- SignalEyewear that reads the wearer's facial muscles continuously
- SignalFDA New Guidance Enables Multi-Mutation Gene Editing Trials; CRISPR Pipeline Expands
- SignalGLP-1 penetration in Europe is estimated at about 2% of the population
- SignalGLP-1 users track fibre, protein, and calories more and plan to spend more on health
- SignalGLP-1-linked muscle loss spawns products such as weighted vests designed for women
- SignalGene-editing cargo crossed the blood-brain barrier in 2025 and a $1.5 billion pact followed
- SignalHands-free gameplay through a consumer EEG headset
- SignalHuman augmentation market projected at $1.39 trillion by 2034
- SignalHuman genome sequencing fell from a decade to a single day
- SignalImplanted interfaces enter broader clinical trials
- SignalKAUST develops precise large-fragment gene insertion method for crops, published in Nature Biotechnology
- SignalLongevity investment up 220% to $8.5 billion with animal lifespans extended 30-74%
- SignalMD Anderson phase 1 trial reported disease stabilization in pancreatic cancer
- SignalMIT Technology Review — 10 Breakthrough Technologies 2026: AI Drug Discovery, Backward Molecule Design
- SignalMSK trial reports 90% survival among immune responders in pancreatic cancer
- SignalNeuralink Expands Human Trials to 21 Participants — VOICE Trial Targets 140 Words/min
- SignalNo geroprotector yet proven both safe and effective in humans
- SignalOne in six US households tried GLP-1s by July 2024 and cut grocery spend about 6%
- SignalOver 200 exosome clinical trials since 2022, with yields reported up to fifty-fold higher
- SignalPatients increasingly ask doctors for a named GLP-1 brand
- SignalPersonalized vaccine plus pembrolizumab cut recurrence or death risk by 49% in melanoma
- SignalPhase 1 trial shows HIF-2 alpha inhibitor casdatifan produces durable tumor responses in kidney cancer
- SignalPreprint identifies TRIM28 as a stabiliser of ovarian cell identity
- SignalProgramming protein shape as an explicit design layer via CAD blueprint-guided diffusion
- SignalProjections put 25 million Americans on GLP-1 treatment by 2030
- SignalPsilocybin Helps Most Veterans With PTSD, Small Study Shows
- SignalSeven psychedelic candidates have reached FDA Phase 3 trials
- SignalStudy Finds Most Explainable-AI Methods for ECG Diagnosis Miss Clinically Relevant Signal Regions
- SignalUQ researchers identify NMT1 pathway as common target for broad-spectrum antiviral therapy
- SignalUS federal drug agency funds non-hallucinogenic psychedelic development with $11.4 million
- SignalVoice AI platforms hit record deal activity in 2025 with most rated as deploying or scaling
- SignalWearable EDA and heart-rate-variability sensors are credited with up to 84% stress detection accuracy
Objects with this as a secondary topic 73
- Signal82% name a nutrition purchase intent; 63% diagnostics, 60% coaching, 55% devices
- SignalA $200 million public-private partnership was announced in March 2026 to fund further trials
- SignalA projected 100,000 worker shortage in the US by 2028 is used to justify voice agents
- TrendAI turns sleep tracking into predictive health monitoring2 signals
- TrendAdvanced Health and Nutrition3 signals
- SignalAnalysts put Spravato global sales at $2 billion in 2025
- SignalAnimal-free egg white from a Finnish start-up
- SignalAsan Medical Center trained AI on 300,000 records across three hospitals without moving raw data
- SignalBrain health investment projected to avert 267 million DALYs and add $6.2 trillion in GDP
- IssueCarbon for Water1 trends · 0 signals
- SignalClaim that nearly half of cancer cases trace to modifiable factors
- SignalConsumers bought in three or four wellbeing categories in a year; 69% keep two or more habits
- IssueData Helix1 trends · 0 signals
- IssueDemand outruns the care pathway, pushing patients into channels of their own2 trends · 1 signals
- IssueDiet as scalable mental and brain health intervention1 trends · 0 signals
- TrendDiet is being individualised by biology and widened by unfamiliar raw materials7 signals
- SignalEditorial: Crop suitability and food security: the evolution of new technologies
- SignalEight psychedelic candidates hold FDA breakthrough therapy designation
- SignalFDA removes the testosterone cardiovascular black box warning in February 2025
- SignalFDA's Roadmap to Reducing Animal Testing — New Approach Methodologies in drug development
- IssueFinally Graphene1 trends · 0 signals
- SignalFirst Biological Qubit Created from Living Cell Protein — UChicago PME Breakthrough
- IssueFresh Threads1 trends · 0 signals
- SignalGLP-1 adoption pushes demand towards smaller portions and higher-protein formats
- SignalGalleri Blood Test Fails to Reduce Late-Stage Cancers in Major NHS Trial
- IssueGeneric wellness gives way to life-stage and physiology-specific demand1 trends · 1 signals
- IssueGenetic material in water and soil as continuous biodiversity monitoring1 trends · 0 signals
- TrendHealth shifts from episodic and institution-led to continuous and consumer-led6 signals
- SignalHome sleep apnea testing market projected to reach $966 million by 2035
- SignalIBM and Moderna ran the largest quantum protein folding simulation to date in 2025
- SignalIBM quantum protein simulation / Microsoft & Quantinuum quantum error correction in Nature (800x logical qubits)
- SignalInterest reaches 63% for health insights and diagnostics, 60% coaching, 54% devices
- SignalLifestyle and sensory tools draw 48% interest; devices and smart environments 55%
- TrendMaterials Revolution3 signals
- IssueMental privacy and voluntariness in enhancement adoption1 trends · 0 signals
- SignalMore than 400 billion dollars of pharma commitments to US facilities create a new AI testbed
- IssueNo approved therapy, unsettled dosing units and an unresolved manufacturing bottleneck1 trends · 1 signals
- SignalObstructive sleep apnea estimated to affect one billion people, mostly undiagnosed
- SignalOne high-risk program reports 100 patients monthly and a 200 percent coaching workforce increase
- IssuePer-patient cost above $100,000 could confine the therapy to well-resourced health systems1 trends · 0 signals
- SignalPerfect Day, Nestle and EVERY have moved fermentation-derived proteins onto retail shelves
- SignalPharma companies report agents already running medical writing and analysis tasks
- TrendProducts are wrapped in data, diagnostics, coaching, monitoring, and subscriptions5 signals
- SignalProtein found in living cells turned into functioning qubit — UChicago PME
- TrendProviders move from reactive care to proactive, decentralised, personalised models5 signals
- TrendPsychedelic developers converge on FDA approval as the main route to scale3 signals
- SignalPwC forecasts $1 trillion of annual US health spending to shift over the next decade
- SignalPwC's Global Health Report names prevention, prediction, decentralisation, and outcomes
- SignalPwC's separate healthy living research finds demand for health-friendly homes and at-home tracking
- SignalQuantum-level simulation resolves how protons move through water
- SignalReconstructing what a person is looking at from brain scans
- SignalReport's list of emerging applications, some still at research level
- IssueSecurity for medical devices as they approach end of life1 trends · 0 signals
- IssueSimulation cannot count as regulatory evidence because shared validation standards do not exist1 trends · 1 signals
- SignalSleep is a top goal for 40% but only 32% track it, and just 56% rate their sleep well
- SignalStanford reports an AI model predicting disease risk from sleep study data
- SignalStudy finds consumer wearable heart-rate data tracks state-level economic hardship in the US
- TrendTechnological Vulnerabilities3 signals
- TrendTechnology 5: microbes given transferred genes produce target molecules in fermentation tanks2 signals
- TrendTechnology 8: molecular behaviour modelled directly instead of approximated3 signals
- SignalTestosterone, hair transplant and steroid markets scale up around male appearance anxiety
- IssueThe Power of Radio1 trends · 0 signals
- SignalThe US Inflation Reduction Act and health technology assessment regimes are named as pricing pressure
- TrendThe first health move becomes digital, with AI and wearables answering before care does3 signals
- IssueThe gap between health goals and health behaviour is read as commercial headroom1 trends · 1 signals
- SignalThe quantum drug discovery market is said to have roughly doubled in five years
- TrendTrend 2: health broadens into many measurable dimensions and outruns consumers' sense of progress8 signals
- IssueTrust and safety, not capability, is named as the binding constraint on voice AI in care1 trends · 1 signals
- IssueTrust is a precondition, not a soft variable, because the arrangements have no precedent3 trends · 1 signals
- SignalUNESCO adopts the first global ethical standard for neurotechnology
- SignalUS states begin legislating on neural data ownership
- SignalUnattended home sleep tests among Medicare beneficiaries grew 632.6 percent in a decade
- SignalVoice AI vendors reorient hiring and go-to-market toward healthcare